Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Animal Models

Downregulation of Max dimerization protein 3 is involved in decreased visceral adipose tissue by inhibiting adipocyte differentiation in zebrafish and mice

Abstract

Background:

The diet-induced obesity model of zebrafish (DIO-zebrafish) share a common pathophysiological pathway with mammalian obesity.

Objectives:

We aimed to investigate the role of Max dimerization protein 3 (MXD3) in visceral fat accumulation and adipocyte differentiation, by conducting knockdown experiments using zebrafish and mouse preadipocytes.

Methods:

To identify genes related to visceral adiposity, we conducted transcriptome analyses of human and zebrafish obese populations using the Gene Expression Omnibus and DNA microarray. We then intraperitoneally injected morpholino antisense oligonucleotides (MO-mxd3) to knockdown mxd3 gene expression in DIO-zebrafish and measured several parameters, which reflected human obesity and associated metabolic diseases. Finally, lentiviral Mxd3 shRNA knockdown in mouse 3T3-L1 preadipocytes was conducted. Quantitative PCR analyses of several differentiation markers were conducted during these gene knockdown experiments.

Results:

We found that MXD3 expression was increased in the obese population in humans and zebrafish. Intraperitoneal MO-mxd3 administration to DIO-zebrafish suppressed the increase in body weight, visceral fat accumulation and the size of mature adipocytes. Subsequently, dyslipidemia and liver steatosis were also ameliorated by MO-mxd3. In mouse adipocytes, Mxd3 expression was drastically increased in the early differentiation stage. Mxd3 shRNA inhibited preadipocyte proliferation and adipocyte maturation. Quantitative PCR analyses showed that the early differentiation marker, CCAAT/enhancer-binding protein delta (Cebpd) and late differentiation markers (CCAAT/enhancer-binding protein, alpha and peroxisome proliferator-activated receptor gamma) were downregulated by Mxd3 knockdown in 3T3-L1 cells and DIO-zebrafish. Subsequently, mature adipocyte markers (adiponectin and caveolin 1 for zebrafish, and fatty acid binding protein 4 and stearoyl-coenzyme A desaturase 1 for mouse adipocytes) were also decreased.

Conclusion:

Mxd3 regulates preadipocyte proliferation and early adipocyte differentiation via Cebpd downregulation in vitro and in vivo. Integrated analysis of human and zebrafish transcriptomes allows identification of a novel therapeutic target against human obesity and further associated metabolic disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Li C, Ford ES, McGuire LC, Mokdad AH . Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 2007; 15: 216–224.

    Article  Google Scholar 

  2. Bessesen DH . Update on obesity. J Clin Endocrinol Metab 2008; 93: 2027–2034.

    Article  CAS  Google Scholar 

  3. Ibrahim MM . Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11: 11–18.

    Article  Google Scholar 

  4. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB . Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658–1667.

    Article  Google Scholar 

  5. Reis JP, Macera CA, Araneta MR, Lindsay SP, Marshall SJ, Wingard DL . Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) 2009; 17: 1232–1239.

    Google Scholar 

  6. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ . The biology of white adipocyte proliferation. Obes Rev 2001; 2: 239–254.

    Article  CAS  Google Scholar 

  7. Bluher M . Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009; 117: 241–250.

    Article  CAS  Google Scholar 

  8. Thorne A, Lonnqvist F, Apelman J, Hellers G, Arner P . A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002; 26: 193–199.

    Article  CAS  Google Scholar 

  9. Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999; 48: 94–98.

    Article  CAS  Google Scholar 

  10. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 2002; 51: 2951–2958.

    Article  CAS  Google Scholar 

  11. Lieschke GJ, Currie PD . Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007; 8: 353–367.

    Article  CAS  Google Scholar 

  12. Henderson RJ, Tocher DR . The lipid composition and biochemistry of freshwater fish. Prog Lipid Res 1987; 26: 281–347.

    Article  CAS  Google Scholar 

  13. Holtta-Vuori M, Salo VT, Nyberg L, Brackmann C, Enejder A, Panula P et al. Zebrafish: gaining popularity in lipid research. Biochem J 2010; 429: 235–242.

    Article  Google Scholar 

  14. Morais S, Knoll-Gellida A, Andre M, Barthe C, Babin PJ . Conserved expression of alternative splicing variants of peroxisomal acyl-CoA oxidase 1 in vertebrates and developmental and nutritional regulation in fish. Physiol Genomics 2007; 28: 239–252.

    Article  CAS  Google Scholar 

  15. Song Y, Cone RD . Creation of a genetic model of obesity in a teleost. FASEB J 2007; 21: 2042–2049.

    Article  CAS  Google Scholar 

  16. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, Hall C et al. Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 2009; 104: 952–960.

    Article  CAS  Google Scholar 

  17. Oka T, Nishimura Y, Zang L, Hirano M, Shimada Y, Wang Z et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiology 2010; 10: 21.

    Article  Google Scholar 

  18. Tainaka T, Shimada Y, Kuroyanagi J, Zang L, Oka T, Nishimura Y et al. Transcriptome analysis of anti-fatty liver action by Campari tomato using a zebrafish diet-induced obesity model. Nutr Metab (Lond) 2011; 8: 88.

    Article  CAS  Google Scholar 

  19. Parichy DM, Mellgren EM, Rawls JF, Lopes SS, Kelsh RN, Johnson SL . Mutational analysis of endothelin receptor b1 (rose) during neural crest and pigment pattern development in the zebrafish Danio rerio. Dev Biol 2000; 227: 294–306.

    Article  CAS  Google Scholar 

  20. Westerfield M . A Guide for the Laboratory Use of Zebrafish (Danio rerio) 4th edn. University of Oregon Press: Eugene, OR, 2007.

    Google Scholar 

  21. Hasumura T, Shimada Y, Kuroyanagi J, Nishimura Y, Meguro S, Takema Y et al. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutr Metab (Lond) 2012; 9: 73.

    Article  Google Scholar 

  22. Jones KS, Alimov AP, Rilo HL, Jandacek RJ, Woollett LA, Penberthy WT . A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development. Nutr Metab (Lond) 2008; 5: 23.

    Article  Google Scholar 

  23. Flynn EJ 3rd, Trent CM, Rawls JF . Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J Lipid Res 2009; 50: 1641–1652.

    Article  CAS  Google Scholar 

  24. Nishio S, Gibert Y, Bernard L, Brunet F, Triqueneaux G, Laudet V . Adiponectin and adiponectin receptor genes are coexpressed during zebrafish embryogenesis and regulated by food deprivation. Dev Dyn 2008; 237: 1682–1690.

    Article  CAS  Google Scholar 

  25. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG et al. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 1995; 14: 5646–5659.

    Article  CAS  Google Scholar 

  26. Hardwick KG, Johnston RC, Smith DL, Murray AW . MAD3 encodes a novel component of the spindle checkpoint which interacts with Bub3p, Cdc20p, and Mad2p. J Cell Biol 2000; 148: 871–882.

    Article  CAS  Google Scholar 

  27. Queva C, McArthur GA, Iritani BM, Eisenman RN . Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol Cell Biol 2001; 21: 703–712.

    Article  CAS  Google Scholar 

  28. Gore Y, Lantner F, Hart G, Shachar I . Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression. Mol Biol Cell 2010; 21: 1864–1871.

    Article  CAS  Google Scholar 

  29. Yun JS, Rust JM, Ishimaru T, Diaz E . A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation. Mol Cell Biol 2007; 27: 8178–8189.

    Article  CAS  Google Scholar 

  30. Barisone GA, Ngo T, Tran M, Cortes D, Shahi MH, Nguyen TV et al. Role of MXD3 in proliferation of DAOY human medulloblastoma cells. PLoS One 2012; 7: e38508.

    Article  CAS  Google Scholar 

  31. Pulverer B, Sommer A, McArthur GA, Eisenman RN, Luscher B . Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1. J Cell Physiol 2000; 183: 399–410.

    Article  CAS  Google Scholar 

  32. Hermeking H, Wolf DA, Kohlhuber F, Dickmanns A, Billaud M, Fanning E et al. Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts. Proc Natl Acad Sci USA 1994; 91: 10412–10416.

    Article  CAS  Google Scholar 

  33. Norton JD, Deed RW, Craggs G, Sablitzky F . Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol 1998; 8: 58–65.

    CAS  PubMed  Google Scholar 

  34. Moldes M, Boizard M, Liepvre XL, Feve B, Dugail I, Pairault J . Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem J 1999; 344 (Pt 3): 873–880.

    Article  CAS  Google Scholar 

  35. Park KW, Waki H, Villanueva CJ, Monticelli LA, Hong C, Kang S et al. Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation. Mol Endocrinol 2008; 22: 2038–2048.

    Article  CAS  Google Scholar 

  36. Hurlin PJ, Huang J . The MAX-interacting transcription factor network. Semin Cancer Biol 2006; 16: 265–274.

    Article  CAS  Google Scholar 

  37. Foley KP, McArthur GA, Queva C, Hurlin PJ, Soriano P, Eisenman RN . Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J 1998; 17: 774–785.

    Article  CAS  Google Scholar 

  38. Schreiber-Agus N, Meng Y, Hoang T, Hou H Jr., Chen K, Greenberg R et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 1998; 393: 483–487.

    Article  CAS  Google Scholar 

  39. Heath VJ, Gillespie DA, Crouch DH . Inhibition of the terminal stages of adipocyte differentiation by cMyc. Exp Cell Res 2000; 254: 91–98.

    Article  CAS  Google Scholar 

  40. Cao Z, Umek RM, McKnight SL . Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991; 5: 1538–1552.

    Article  CAS  Google Scholar 

  41. Wu Z, Bucher NL, Farmer SR . Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol Cell Biol 1996; 16: 4128–4136.

    Article  CAS  Google Scholar 

  42. Niehof M, Manns MP, Trautwein C . CREB controls LAP/C/EBP beta transcription. Mol Cell Biol 1997; 17: 3600–3613.

    Article  CAS  Google Scholar 

  43. Reusch JE, Colton LA, Klemm DJ . CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 2000; 20: 1008–1020.

    Article  CAS  Google Scholar 

  44. Si J, Yu X, Zhang Y, DeWille JW . Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Mol Cancer 2010; 9: 92.

    Article  Google Scholar 

  45. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F . SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004; 86: 839–848.

    Article  CAS  Google Scholar 

  46. Edgar R, Domrachev M, Lash AE . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207–210.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank S Ichikawa for her experimental assistance; A Suzuki for zebrafish breeding and maintenance; and R Ikeyama and Y Tamura for secretarial assistance. This work was supported in part by a KAKENHI (23659136) Grant-in-Aid for Scientific Research, Science and Technology Agency, and the New Energy and Industrial Technology Development Organization in Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T Tanaka.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, Y., Kuroyanagi, J., Zhang, B. et al. Downregulation of Max dimerization protein 3 is involved in decreased visceral adipose tissue by inhibiting adipocyte differentiation in zebrafish and mice. Int J Obes 38, 1053–1060 (2014). https://doi.org/10.1038/ijo.2013.217

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2013.217

Keywords

This article is cited by

Search

Quick links